8-K: INVO Fertility Executes 1-for-8 Reverse Stock Split

INVO Fertility, Inc. announced a 1-for-8 reverse stock split to be effective November 28, 2025, impacting its common stock trading on Nasdaq.

Summary

• INVO Fertility, Inc. (INVO) filed a Certificate of Change with the Nevada Secretary of State to effect a 1-for-8 reverse stock split of its issued and outstanding and authorized common stock.
• The reverse stock split became effective at 12:01 a.m., Eastern Time, on Friday, November 28, 2025.
• The Company's Common Stock began trading on a split-adjusted basis on The Nasdaq Stock Market on November 28, 2025.
• Every 8 shares of issued and outstanding common stock were automatically reclassified and combined into one share, without any change in the par value per share.
• The Company's authorized shares of Common Stock were proportionately adjusted to 6,250,000 shares.
• Proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants, and shares reserved for equity incentive compensation plans.
• No fractional shares were issued; stockholders who would have received fractional shares had their holdings rounded up to the next whole share.
• The Common Stock continues to trade on The Nasdaq Capital Market under the existing symbol IVF, but has been assigned a new CUSIP number (44984F807).
• Immediately after the reverse stock split, the company has approximately 1,891,151 shares of common stock issued and outstanding.

Sentiment

Score: 3

Explanation: A reverse stock split is generally viewed negatively by the market as it often signals a company's struggle to maintain its stock price above exchange minimums. While it prevents delisting, it doesn't address fundamental issues and can lead to further investor skepticism.

Positives

• The reverse stock split aims to increase the per-share price, which is often a requirement to maintain listing on The Nasdaq Capital Market, thereby avoiding potential delisting.
• Stockholders who would have been entitled to receive fractional shares had their holdings rounded up to the next whole share, which is a minor benefit.

Negatives

• A reverse stock split typically indicates a significantly low stock price, often below exchange minimums, reflecting poor market performance or investor sentiment.
• The action does not address the underlying operational or financial issues that may have led to the low stock price.
• Historically, reverse stock splits can sometimes be followed by further stock price declines due to continued negative market perception.

Risks

• The company's stock price may continue to decline even after the reverse split, potentially leading to future compliance issues with Nasdaq's listing requirements or eventual delisting.
• The reverse split does not guarantee long-term compliance with Nasdaq's minimum bid price requirement.
• All forward-looking statements involve risks, uncertainties, and contingencies, many of which are beyond the company's control, which may cause actual results to differ materially from anticipated results.

Future Outlook

The reverse stock split is a strategic move to increase the per-share trading price, which is crucial for maintaining compliance with Nasdaq listing requirements. The company continues its focus on expanding assisted reproductive technology (ART) care, building and acquiring fertility clinics, and selling its INVOcell technology solution into third-party owned and operated fertility clinics.

Management Comments

• INVO Fertility, Inc. (INVO) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-8 reverse split of its issued and outstanding and authorized common stock effective as of 12:01 a.m. Eastern Time on November 28, 2025.

Industry Context

INVO Fertility operates in the healthcare services fertility market, focusing on assisted reproductive technology (ART) care, particularly through its INVOcell medical device for intravaginal culture (IVC) procedures. A reverse stock split is a corporate action often taken by companies whose stock price has fallen significantly, potentially indicating challenges within the company's specific niche, broader market pressures affecting smaller cap companies, or a need to meet exchange minimum bid price requirements to avoid delisting.

Corporate Governance

Stakeholder Impact

• Shareholders: Existing shareholders will own fewer shares, but each share will have a proportionately higher price. Fractional shares were rounded up. The primary impact is the potential for continued Nasdaq listing, but also the negative signal of the underlying low share price and potential for further dilution or price volatility.
• Employees: No direct impact on employees is mentioned in the filing, but a struggling stock price can affect morale and the value of equity-based compensation.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is mentioned from the reverse split itself.

Next Steps

• Continued trading of Common Stock on The Nasdaq Capital Market under the existing symbol IVF with a new CUSIP number.
• Ongoing operations focused on building, acquiring, and operating fertility clinics and distributing INVOcell technology.

Key Dates

Recommendation

While a reverse stock split is typically a negative indicator reflecting a low share price, this action is a technical move to maintain Nasdaq listing, which can prevent further negative consequences like delisting. For a seasoned investor, it suggests caution. It's not a 'buy' signal as it doesn't indicate fundamental improvement, nor a 'strong sell' without further information on the company's operational performance post-split. A 'hold' with close monitoring of future financial results and market reception to the split is prudent, acknowledging the inherent risks associated with companies undertaking such actions.

Keywords

Reverse Stock Split, INVO Fertility, IVF, Nasdaq, Common Stock, Corporate Action, Fertility Market, INVOcell, Healthcare Services